165 related articles for article (PubMed ID: 33708397)
21. Cocrystallization for successful drug delivery.
Sun CC
Expert Opin Drug Deliv; 2013 Feb; 10(2):201-13. PubMed ID: 23256822
[TBL] [Abstract][Full Text] [Related]
22. New Lidocaine-Based Pharmaceutical Cocrystals: Preparation, Characterization, and Influence of the Racemic vs. Enantiopure Coformer on the Physico-Chemical Properties.
Ma P; Toussaint B; Roberti EA; Scornet N; Santos Silva A; Castillo Henríquez L; Cadasse M; Négrier P; Massip S; Dufat H; Hammad K; Baraldi C; Gamberini MC; Richard C; Veesler S; Espeau P; Lee T; Corvis Y
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111588
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound assisted cocrystallization from solution (USSC) containing a non-congruently soluble cocrystal component pair: Caffeine/maleic acid.
Aher S; Dhumal R; Mahadik K; Paradkar A; York P
Eur J Pharm Sci; 2010 Dec; 41(5):597-602. PubMed ID: 20801215
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and Characterization of a (-)-Epicatechin and Barbituric Acid Cocrystal: Single-Crystal X-ray Diffraction and Vibrational Spectroscopic Studies.
Budziak-Wieczorek I; Maciołek U
ACS Omega; 2021 Mar; 6(12):8199-8209. PubMed ID: 33817479
[TBL] [Abstract][Full Text] [Related]
25. Experimental cocrystal screening and solution based scale-up cocrystallization methods.
Malamatari M; Ross SA; Douroumis D; Velaga SP
Adv Drug Deliv Rev; 2017 Aug; 117():162-177. PubMed ID: 28811184
[TBL] [Abstract][Full Text] [Related]
26. Consistency and variability of cocrystals containing positional isomers: the self-assembly evolution mechanism of supramolecular synthons of cresol-piperazine.
Wang N; Huang X; Chen L; Yang J; Li X; Ma J; Bao Y; Li F; Yin Q; Hao H
IUCrJ; 2019 Nov; 6(Pt 6):1064-1073. PubMed ID: 31709062
[TBL] [Abstract][Full Text] [Related]
27. Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility.
Vasilev NA; Surov AO; Voronin AP; Drozd KV; Perlovich GL
Int J Pharm; 2021 Apr; 599():120441. PubMed ID: 33675927
[TBL] [Abstract][Full Text] [Related]
28. Improving the Physicochemical and Biopharmaceutical Properties of Active Pharmaceutical Ingredients Derived from Traditional Chinese Medicine through Cocrystal Engineering.
Guan D; Xuan B; Wang C; Long R; Jiang Y; Mao L; Kang J; Wang Z; Chow SF; Zhou Q
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959440
[TBL] [Abstract][Full Text] [Related]
29. Drug-drug cocrystals of antituberculous 4-aminosalicylic acid: Screening, crystal structures, thermochemical and solubility studies.
Drozd KV; Manin AN; Churakov AV; Perlovich GL
Eur J Pharm Sci; 2017 Mar; 99():228-239. PubMed ID: 28011126
[TBL] [Abstract][Full Text] [Related]
30. Application of 1-Hydroxy-4,5-Dimethyl-Imidazole 3-Oxide as Coformer in Formation of Pharmaceutical Cocrystals.
Wróblewska A; Śniechowska J; Kaźmierski S; Wielgus E; Bujacz GD; Mlostoń G; Chworos A; Suwara J; Potrzebowski MJ
Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32326428
[TBL] [Abstract][Full Text] [Related]
31. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
[TBL] [Abstract][Full Text] [Related]
32. In Vitro-In Vivo Correlation in Cocrystal Dissolution: Consideration of Drug Release Profiles Based on Coformer Dissolution and Absorption Behavior.
Kataoka M; Minami K; Takagi T; Amidon GE; Yamashita S
Mol Pharm; 2021 Nov; 18(11):4122-4130. PubMed ID: 34618448
[TBL] [Abstract][Full Text] [Related]
33. Study on the effect of solvent on cocrystallization of CL-20 and HMX through theoretical calculations and experiments.
Zhao X; Li J; Quan S; Fu X; Meng S; Jiang L; Fan X
RSC Adv; 2022 Jul; 12(33):21255-21263. PubMed ID: 35975069
[TBL] [Abstract][Full Text] [Related]
34. Impact of pharmaceutical cocrystals: the effects on drug pharmacokinetics.
Shan N; Perry ML; Weyna DR; Zaworotko MJ
Expert Opin Drug Metab Toxicol; 2014 Sep; 10(9):1255-71. PubMed ID: 25089559
[TBL] [Abstract][Full Text] [Related]
35. Multicomponent Pharmaceutical Cocrystals: A Novel Approach for Combination Therapy.
Srivastava D; Fatima Z; Kaur CD
Mini Rev Med Chem; 2018; 18(14):1160-1167. PubMed ID: 29512461
[TBL] [Abstract][Full Text] [Related]
36. Recent Advancements in Pharmaceutical Cocrystals, Preparation Methods, and their Applications.
Manchanda D; Kumar A; Nanda A
Curr Pharm Des; 2021; 27(44):4477-4495. PubMed ID: 33858309
[TBL] [Abstract][Full Text] [Related]
37. Critical Analysis and Optimization of Stoichiometric Ratio of Drug-Coformer on Cocrystal Design: Molecular Docking, In Vitro and In Vivo Assessment.
Dhibar M; Chakraborty S; Basak S; Pattanayak P; Chatterjee T; Ghosh B; Raafat M; Abourehab MAS
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259428
[TBL] [Abstract][Full Text] [Related]
38. Development of a pharmaceutical cocrystal with solution crystallization technology: Preparation, characterization, and evaluation of myricetin-proline cocrystals.
Liu M; Hong C; Yao Y; Shen H; Ji G; Li G; Xie Y
Eur J Pharm Biopharm; 2016 Oct; 107():151-9. PubMed ID: 27395394
[TBL] [Abstract][Full Text] [Related]
39. Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications.
Guo M; Sun X; Chen J; Cai T
Acta Pharm Sin B; 2021 Aug; 11(8):2537-2564. PubMed ID: 34522597
[TBL] [Abstract][Full Text] [Related]
40. Theoretical insights into the structures and mechanical properties of HMX/NQ cocrystal explosives and their complexes, and the influence of molecular ratios on their bonding energies.
Li YX; Chen SS; Ren FD
J Mol Model; 2015 Sep; 21(9):245. PubMed ID: 26318201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
